Stock Information

• Piper Sandler Maintains Overweight on CytomX Therapeutics, Raises Price Target to $12
  Mon, Mar 23, 2026 12:51 PM
• CytomX Therapeutics shares are trading higher after Barclays raised its price target on the stock from $10 to $16.
  Thu, Mar 19, 2026 1:23 PM
• 12 Health Care Stocks Moving In Thursday's Intraday Session
  Thu, Mar 19, 2026 1:05 PM
• Barclays Maintains Overweight on CytomX Therapeutics, Raises Price Target to $16
  Thu, Mar 19, 2026 10:25 AM
• Jefferies Maintains Buy on CytomX Therapeutics, Raises Price Target to $16
  Wed, Mar 18, 2026 2:28 PM
• Why Is CytomX Therapeutics Stock Falling On Wednesday?
  Wed, Mar 18, 2026 1:06 PM
• CytomX Therapeutics shares are trading lower after the company announced the pricing of its $250 million public offering of 45,990,567 shares at $5.30 each.
  Wed, Mar 18, 2026 11:47 AM
• CytomX Therapeutics: Great News, But Early Data Do Not Quite Justify This Price Level
  Wed, Mar 18, 2026 10:03 AM
• Guggenheim Maintains Buy on CytomX Therapeutics, Raises Price Target to $15
  Wed, Mar 18, 2026 9:09 AM
• CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
  Wed, Mar 18, 2026 2:46 AM

Financial data not available